Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Phathom Pharmaceuticals, Inc.

Clinical trials sponsored by Phathom Pharmaceuticals, Inc., explained in plain language.

Phathom Pharmaceuticals, Inc. PHAT NASDAQ

A biopharmaceutical company developing gastrointestinal treatments.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

New pill could ease swallowing for EoE patients

Disease control Ongoing

This study tests a once-daily pill called vonoprazan against a placebo in 80 adults with eosinophilic esophagitis (EoE), a condition that makes swallowing difficult. The main goal is to see if the drug reduces inflammation in the esophagus after 12 weeks. Researchers will also ch…

Phase: PHASE2 • Sponsor: Phathom Pharmaceuticals, Inc. • Aim: Disease control

Last updated Jul 01, 2026 00:00 UTC